135 related articles for article (PubMed ID: 35834642)
1. Hyaluronidase as a Successful Treatment Modality for Scleroderma-Induced Microstomia.
Chopra D; Brehm JE; Morrison B
Dermatol Surg; 2022 Sep; 48(9):1014-1015. PubMed ID: 35834642
[No Abstract] [Full Text] [Related]
2. Hyaluronidase Treatment of Scleroderma-Induced Microstomia.
Melvin OG; Hunt KM; Jacobson ES
JAMA Dermatol; 2019 Jul; 155(7):857-859. PubMed ID: 31141116
[No Abstract] [Full Text] [Related]
3. Hyaluronidase Injections for Oral Microstomia in Systemic Sclerosis and Mixed Connective Tissue Disease.
Min MS; Goldman N; Mazori DR; Guo LN; Vleugels RA; LaChance AH
JAMA Dermatol; 2023 Dec; 159(12):1393-1395. PubMed ID: 37851438
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with hyaluronidase in dermatology].
Wozniak KD; Braun W
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
[No Abstract] [Full Text] [Related]
5. [Hyaluronidase in scleroderma].
JOHANSSON S; MOLLER F
Nord Med; 1957 Jul; 58(30):1086-9. PubMed ID: 13465029
[No Abstract] [Full Text] [Related]
6. Use of hyaluronidase in scleroderma.
CLAESSON U; LINDQUIST B
Acta Paediatr (Stockh); 1953 May; 42(3):278-81. PubMed ID: 13079763
[No Abstract] [Full Text] [Related]
7. [Treatment of scleroderma with depolymerizing agents].
Konopík J; Krs V
Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
[No Abstract] [Full Text] [Related]
8. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Nitzschner H
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
[No Abstract] [Full Text] [Related]
9. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
10. [Treatment of scleroderma].
Wüthrich B
Schweiz Rundsch Med Prax; 1973 Sep; 62(38):1149-55. PubMed ID: 4148265
[No Abstract] [Full Text] [Related]
11. Peristomal morphoea in a patient with systemic sclerosis.
Jiang KW; Zagarella SS; Chan L; Harris A
Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
[No Abstract] [Full Text] [Related]
12. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
Wozniak KD; Braun W
Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
[No Abstract] [Full Text] [Related]
13. Provision of resin bonded bridgework for a patient with microstomia secondary to scleroderma.
McKenna G; Hayes M; Burke FM
Eur J Prosthodont Restor Dent; 2012 Jun; 20(2):56-60. PubMed ID: 22852520
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of recurrent generalized morphea and systemic sclerosis.
Hayashi M; Ichiki Y; Kitajima Y
Acta Derm Venereol; 2009; 89(3):329-30. PubMed ID: 19479146
[No Abstract] [Full Text] [Related]
15. [Microstomia as a complication of scleroderma].
Phoa KH; de Baat P; de Baat C
Ned Tijdschr Tandheelkd; 2003 Nov; 110(11):457-9. PubMed ID: 14669488
[TBL] [Abstract][Full Text] [Related]
16. [The sclerodermas].
Huriez C
Lille Med; 1971 Dec; 16(10):1358-69. PubMed ID: 5160880
[No Abstract] [Full Text] [Related]
17. Scleroderma in children.
Zulian F
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
[TBL] [Abstract][Full Text] [Related]
18. Review of the Current Medical and Surgical Treatment Options for Microstomia in Patients With Scleroderma.
Gonzalez CD; Pamatmat JJ; Hutto JC; Goff HW
Dermatol Surg; 2021 Jun; 47(6):780-784. PubMed ID: 33867466
[TBL] [Abstract][Full Text] [Related]
19. Fabricating sectional-collapsible complete dentures for an edentulous patient with microstomia induced by scleroderma.
Dikbas I; Koksal T; Kazazoglu E
Quintessence Int; 2007 Jan; 38(1):15-22. PubMed ID: 17216903
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological improvement of scleromyxedema-induced microstomia after hyaluronidase injection.
Akaslan TÇ; Yıldız P; Onsun N
J Cosmet Dermatol; 2022 Oct; 21(10):4319-4322. PubMed ID: 35441782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
